covid-19 vaccine featured image
News Pharmaceutical & Biotech Stories

New Zealand Signs Deal with Pfizer, BioNTech for COVID-19 Vaccine

The New Zealand Government has signed a deal with Pfizer Inc. and BioNTech to secure 1.5 million doses of potential coronavirus vaccine.

In a statement said by Research, Science & Innovation Minister Megan Woods, the government is in talks with other drug companies as well to ensure sufficient COVID-19 vaccines for the whole population.

Officials said talks were continuing with other drug companies to secure more vaccine supplies for the country of 5 million people and further announcements were expected next month.

“The additional agreements will ensure that once the portfolio is completed, we will have sufficient COVID-19 vaccines for the whole population,” Woods said in a statement.

The Pfizer-BioNTech vaccine, BNT162b2, is one of the leading COVID-19 vaccine candidates in the race to get regulatory approval in the United States, Canada, and Europe.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS

Send this to a friend